Why Novartis and Global Giants are Scaling Back in India
FTA promises fail to deter big pharma exit

Novartis AG’s exit from its listed Indian subsidiary highlights a growing trend of “Big Pharma” companies divesting from the hyper-competitive…

India has to focus on monetising FTAs

Despite signing multiple Free Trade Agreements, India needs to improve their effective monetisation as low adoption—especially among MSMEs—continues to limit…

Oman and New Zealand FTAs Inked as India Pivots to Combat ‘Trump Tariffs’
The year of FTAs

India has diversified export destinations, but should align with global standards too